EUVIMEDEUVIMED entdecken
Open Access

Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma

Johnny Cheuk-On Tang, Dessy Chan, Po-Yee Chung, Yijiang Liu, Alfred King-Yin Lam, Simon Law, Wolin Huang, Albert Sun-Chi Chan, Kim-Hung Lam, Yuanyuan Zhou

International Journal of Molecular Medicine · 2024

DOI: 10.3892/ijmm.2024.5435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2024. Verfasst von Johnny Cheuk-On Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jean-Marie Lehn Laboratory, Guangzhou Huashang College, Guangzhou, Guangdong 511300, P.R. China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Chemokine CCL5, Down-Regulation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) is a particularly aggressive form of cancer with high mortality. In the present study, a novel 8‑hydroxyquinoline derivative (91b1) was investigated for its anticancer activities in ESCC along with its associated mechanisms. The in vitro cytotoxic effect of 91b1 were evaluated across five ESCC cell lines using MTS assay, with cisplatin serving as a comparative standard. Changes in gene expression profile were identified by cDNA microarray and further validated by qualitative PCR and immunostaining. Additionally, protein levels of the most notably downregulated target in archival ESCC samples were also studied. 91b1 demonstrated comparable anticancer effect with cisplatin. Notably, chemokine ligand 5 (Ccl5) was identified as the most substantially downregulated gene, with its suppression at both mRNA and protein expression in ESCC cells, exhibiting a dose‑dependent manner. The recombinant human protein of CCL5 enhanced the invasion of ESCC cells using the Transwell assay. The upregulation of CCL5 protein was also detected in 50% of ESCC cell lines. CCL5 was also overexpressed in 76.9% of ESCC specimens. The overall results indicated that 91b1 could effectively induce anticancer effect on ESCC cells through downregulating CCL5 expression with suppression of tumor invasion. Overall, these findings suggested that 91b1 effectively inhibited ESCC cell proliferation and tumor invasion by downregulating CCL5 expression, highlighting its potential as a therapeutic agent for ESCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsChemokine CCL5Down-RegulationGene Expression Regulation, NeoplasticHumansCell Line, TumorNeoplasm InvasivenessOxyquinolineAntineoplastic AgentsEsophageal Squamous Cell CarcinomaCell ProliferationMaleFemaleCell MovementCisplatinCarcinoma, Squamous Cell

Stichwörter der Autor:innen

chemokine (C‑C motif) ligand 5esophageal squamous cell carcinomaquinoline derivatives

Substanzen

Chemokine CCL5OxyquinolineAntineoplastic AgentsCCL5 protein, humanCisplatin

Autor:innen und Institutionen

  • Jean-Marie Lehn Laboratory, Guangzhou Huashang College, Guangzhou, Guangdong 511300, P.R. China.
  • State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong, SAR 999077, P.R. China.
  • School of Biological Sciences, Nanyang Technological University, Singapore 639798, Republic of Singapore.
  • Griffith Medical School, Griffith University, Gold Coast, QLD 4222, Australia.
  • Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, SAR 999077, P.R. China.
  • President Office, Guangzhou Huashang College, Guangzhou, Guangzhou 511300, P.R. China.

Zitieren

APA

Tang, J. C., Chan, D., Chung, P. Y., Liu, Y., Lam, A. K., Law, S., Huang, W., Chan, A. S., Lam, K. H., & Zhou, Y. (2024). Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2024.5435

Vancouver

Tang JC, Chan D, Chung PY, Liu Y, Lam AK, Law S, et al. Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma. International Journal of Molecular Medicine. 2024. doi:10.3892/ijmm.2024.5435

BibTeX
@article{Tang2024,
  author = {Tang, Johnny Cheuk-On and Chan, Dessy and Chung, Po-Yee and Liu, Yijiang and Lam, Alfred King-Yin and Law, Simon and Huang, Wolin and Chan, Albert Sun-Chi and Lam, Kim-Hung and Zhou, Yuanyuan},
  title = {Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  doi = {10.3892/ijmm.2024.5435}
}
Kostenlos starten →